Education
About Us
Working with TipRanks
Follow Us
Aethlon Medical Inc (AEMD)
NASDAQ:AEMD
Total Valuation
Aethlon Medical has a market cap or net worth of $5.52M. The enterprise value is $7.91M.
Market Cap$5.52M
Enterprise Value$7.91M
Share Statistics
Aethlon Medical has 16.06M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16.06M
Owned by Insiders2.15%
Owned by Instutions7.95%
Financial Efficiency
Aethlon Medical’s return on equity (ROE) is -2.12 and return on invested capital (ROIC) is -188.42%.
Return on Equity (ROE)-211.71%
Return on Assets (ROA)-148.05%
Return on Invested Capital (ROIC)-188.42%
Return on Capital Employed (ROCE)-196.95%
Revenue Per Employee$0
Profits Per Employee-$682,758.143
Employee Count14
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Aethlon Medical is -0.36. Aethlon Medical’s PEG ratio is 0.02.
PE Ratio-0.36
PS Ratio0.00
PB Ratio0.75
Price to Fair Value0.75
Price to FCF-0.42
Price to Operating Cash Flow-0.43
PEG Ratio0.02
Income Statement
In the last 12 months, Aethlon Medical had revenue of $0.00 and earned -$9.56M in profits. Earnings per share was -$1.59.
Revenue$0.00
Gross Profit-$171.89K
Operating Income-$9.82M
Pretax Income-$9.56M
Net Income-$9.56M
EBITDA-9.37M
Earnings Per Share (EPS)-1.59
Cash Flow
In the last 12 months, operating cash flow was -$5.98B and capital expenditures -$2.20M, giving a free cash flow of -$5.98B billion.
Operating Cash Flow-$5.98B
Free Cash Flow-$5.98B
Free Cash Flow per Share-$372.18
Dividends & Yields
Aethlon Medical pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-238.80%
Earnings Yield-280.83%
Stock Price Statistics
Beta1.10
52-Week Price Change-75.17%
50-Day Moving Average0.49
200-Day Moving Average0.46
Relative Strength Index (RSI)40.07
Average Volume (3m)147.60K
Important Dates
Aethlon Medical upcoming earnings date is Jun 26, 2025, After Close.
Last Earnings DateFeb 12, 2025
Next Earnings DateJun 26, 2025
Ex-Dividend Date―
Financial Position
Aethlon Medical as a current ratio of 3.40, with Debt / Equity ratio of 0.16
Current Ratio3.40
Quick Ratio3.40
Debt to Market Cap0.00
Net Debt to EBITDA0.38
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Aethlon Medical has paid -$2.00 in taxes.
Income Tax-$2.00
Effective Tax Rate>-0.01%
Enterprise Valuation
Aethlon Medical EV to EBITDA ratio is 0.01, with an EV/FCF ratio of 0.01.
EV to Sales0.00
EV to EBITDA0.01
EV to Free Cash Flow0.01
EV to Operating Cash Flow0.02
Balance Sheet
Aethlon Medical has $4.83B in cash and marketable securities with $724.85M in debt, giving a net cash position of -$4.10B billion.
Cash & Marketable Securities$4.83B
Total Debt$724.85M
Net Cash-$4.10B
Net Cash Per Share-$255.31
Tangible Book Value Per Share$2.29
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Aethlon Medical is $7.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$7.00
Price Target Upside1844.44%
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast-100.00%
EPS Growth Forecast68.26%